# Clinical Story Skeleton Review

Date: 2026-05-31

Status: Clinical Story Skeleton v1 reviewed as locked physician-authored clinical scaffold.

Reviewed against:

- Approved Korvin Merrow Brainstorm.
- Reviewer GO from Stacey S.
- Reviewer feedback history.
- `clinical-logic.md`.
- `WORLD_SPEC_KICKOFF.md`.
- `physician-decision-log-01.md`.
- World Spec AutoQC v6.3 indexed requirements.
- World Spec writer playbook.

This review does not rewrite the skeleton, draft the World Spec, create a file inventory, create tasks, write prompts, create golden responses, or create grader guidance.

## Reviewed Skeleton

Korvin Merrow is a 62-year-old male with stable chronic disease before an approximately 3-week decline. Baseline is independent but slowed by chronic illness, with family support, occasional cane use, and mild age-related forgetfulness only.

The clinical arc includes chronic PMR prednisone exposure with recent taper and reconstructable source-of-truth inconsistency, progressive weakness, poor intake, unsteadiness, cognitive slowing, medication-management mistakes, near-fall/lightheadedness, family concern, ED presentation for suspected urinary-source infection with dehydration and AKI risk, and a 6-day hospitalization ending with medical improvement but unresolved discharge safety risk.

The central theme remains: medically improving, operationally dangerous.

## Executive Finding

Overall, Clinical Story Skeleton v1 is aligned with the approved Brainstorm and is strong enough to proceed to Identity Package and Governance Package.

The skeleton should not be expanded into final World Spec prose yet. Its remaining risks are implementation risks for later packages: exact milestone dates, source-of-truth hierarchy, consultant triggers, and traceability into future world files.

## 1. Internal Consistency

### NO ISSUE

Finding: The chronology is internally coherent.

Evidence: The story moves from stable baseline to approximately 3-week decline, escalation at home, ED presentation, HD1 stabilization, HD2 partial improvement and consultant involvement, HD3 PT/OT functional concerns, HD4 consultant tension and steroid-history recognition, HD5 disposition dominance, and HD6 medical improvement with debatable discharge.

Impact: Supports the approved HD6 18:00 world close and gives enough temporal structure for later milestones.

Action required: Preserve this sequence in later milestone planning. Do not convert it into an hour-by-hour timeline at this stage.

### NO ISSUE

Finding: Symptom progression supports the ED presentation and discharge tension.

Evidence: Poor intake, reduced activity, weakness, cognitive slowing, lightheadedness, medication-management mistakes, and near-fall logically lead family to seek care. Persistent functional reserve uncertainty logically supports discharge tension despite improved infection, AKI, hemodynamics, mental status, and intake.

Impact: The discharge problem is earned by the story instead of appearing abruptly at the end.

Action required: Later file planning must give these symptoms independent chart substrates, especially nursing, PT/OT, medication reconciliation, and family communication.

### PLAUSIBLE

Finding: Consultant involvement beginning HD2 and tensions emerging by HD4 is clinically plausible but still under-specified.

Evidence: AKI/HF medication tension, steroid-history uncertainty, and improving-but-not-baseline status naturally justify nephrology, cardiology, and endocrinology involvement during a multi-day admission.

Impact: Good skeleton-level logic. A hostile reviewer may challenge it later if consultant triggers and recommendation timestamps are not made concrete.

Action required: In Governance Package and later World Spec work, define what triggers each consult, what each service is asked, what each service recommends, and when the recommendation becomes time-sensitive.

## 2. Clinical Realism

### VERIFIED

Finding: The skeleton preserves the approved mixed-physiology design.

Evidence: The skeleton explicitly states infection is a contributor, not the entire explanation. It keeps near-fall multi-factorial with poor intake, volume depletion, medication effects, neuropathy, deconditioning, infection physiology, and steroid-related physiology.

Impact: This protects the world from collapsing into either a sepsis-only case or a hidden adrenal insufficiency puzzle.

Action required: Continue to phrase steroid physiology as a competing risk interpretation rather than the final reveal.

### NO ISSUE

Finding: The hospitalization flow is plausible for acute hospital medicine.

Evidence: ED stabilization, partial improvement, PT/OT concern, consultant tension, discharge planning, and unresolved functional safety all reflect common hospital medicine workflows.

Impact: The world remains realistic and not zebra-driven.

Action required: Later documentation should keep consultant positions reasonable and context-dependent.

### PLAUSIBLE

Finding: Steroid-management realism is strong conceptually but requires careful source hierarchy later.

Evidence: The skeleton states chronic prednisone exposure, multiple prior taper attempts, recent taper due to controlled symptoms, and inconsistent documentation/family/patient understanding.

Impact: Strong substrate for the steroid timeline/source-of-truth trap. Risk appears only if later documents make the true steroid state unreconstructable or too obvious.

Action required: Governance Package should define a clear source-of-truth hierarchy and what can be inferred from each source.

### NO ISSUE

Finding: AKI/HF interaction is clinically realistic.

Evidence: The approved Brainstorm and clinical logic include CKD stage 3, HFrEF/CAD, diuretics, ARNI, SGLT2 inhibitor, beta blocker, spironolactone, hypotension risk, renal recovery, and restart timing uncertainty.

Impact: Supports the strongest locked friction: nephrology vs cardiology.

Action required: Later packages should specify which medications are held, restarted, delayed, or require follow-up without turning that into a final task answer.

## 3. Brainstorm Alignment

### VERIFIED

Finding: The skeleton aligns with approved frictions.

Evidence: AKI/HF medication uncertainty supports Nephrology vs Cardiology. Functional reserve and family concern support Family vs Inpatient Medicine. PMR/prednisone uncertainty and persistent symptoms support Emergency/Inpatient Medicine vs Endocrinology.

Impact: No approved friction is orphaned.

Action required: Later Decision Friction Table must preserve all three as perspective conflicts, not information traps.

### VERIFIED

Finding: The skeleton supports all approved world-level traps.

Evidence:

- Steroid timeline/source-of-truth trap: chronic prednisone exposure, recent taper, inconsistent sources.
- HF-AKI medication trap: medication-management mistakes and unresolved restart strategy.
- Buried functional/cognitive status trap: PT/OT concerns, cognitive slowing, family concern, functional reserve uncertainty.
- Sepsis anchoring after partial improvement trap: suspected urinary-source infection improves but does not explain the entire course.
- Discharge plan source-hierarchy trap: medically improved status conflicts with functional and medication-transition risk.

Impact: Trap architecture remains intact.

Action required: Later file strategy must create multi-document substrates for each trap.

### NO ISSUE

Finding: The skeleton supports the approved task concepts.

Evidence: Discharge medication reconciliation, discharge summary generation, transition-of-care planning, post-hospital follow-up, consultant synthesis, and readmission risk review all naturally arise from this hospitalization endpoint.

Impact: Task concepts remain anchored to realistic clinician workflows.

Action required: Do not write task prompts yet. Use the skeleton only to support later task architecture.

## 4. AutoQC Exposure

### VERIFIED

Finding: Temporal architecture is currently strong but must be converted into exact milestones later.

Evidence: World close remains HD6 18:00. The skeleton uses HD1-HD6 progression and keeps task anchors after world close.

Impact: Supports AutoQC 2.41, but later spec must list exact dates/times in Key Milestones and ensure no world file appears after any task anchor.

Action required: Identity/Timeline Package must convert hospital days into a consistent calendar skeleton.

### PLAUSIBLE

Finding: Traceability risk is the largest future exposure.

Evidence: The skeleton names functional decline, steroid uncertainty, consultant tension, medication restart uncertainty, and discharge danger, but does not yet map them to source documents.

Impact: This is appropriate for a skeleton, but later failure under AutoQC 2.48/2.49 is possible if every expected-output fact and trap is not tied to a World File Plan row.

Action required: Carry this forward as a file strategy requirement, not a skeleton revision.

### PLAUSIBLE

Finding: Source-of-truth hierarchy risk remains open.

Evidence: The skeleton depends on inconsistent prednisone history, family understanding, patient recollection, medication history, and documentation.

Impact: AutoQC 2.65 will require explicit hierarchy when authority traps exist.

Action required: Governance Package must define authority hierarchy for medication lists, consultant notes, active orders, family reports, patient recollection, and discharge artifacts.

### PLAUSIBLE

Finding: Workflow risk is downstream, not a skeleton defect.

Evidence: Approved rough tasks remain six, but World Spec AutoQC expects 3-5 distinct catalog workflows and appropriate clinical plus administrative work product mix where relevant.

Impact: The skeleton supports workflow consolidation but does not solve it.

Action required: Address in Task Architecture decisions after Identity and Governance work. Do not modify the skeleton for this.

### PLAUSIBLE

Finding: Authority-chain risk is present by design.

Evidence: Consultant recommendations, inpatient decisions, family concerns, medication reconciliation, and discharge planning will conflict across time and source type.

Impact: Strong if governed; risky if later spec treats "latest note" as automatically authoritative.

Action required: Governance Package should define how current orders, attending plans, consultant recommendations, nursing/PT observations, and family concerns are weighed.

## 5. Reviewer Risk

### NO ISSUE

Finding: Complexity signal is adequate for skeleton stage.

Evidence: The approved Brainstorm already expanded comorbidities and medication specificity. The skeleton correctly focuses on story arc rather than restating the full problem list.

Impact: Reviewer should not require the skeleton itself to list every comorbidity and medication, as long as the future World Spec does.

Action required: Later World Spec must visibly meet the 12-15 comorbidity and 18-22 medication target.

### PLAUSIBLE

Finding: Consultant logic could be challenged if left at skeleton-level detail.

Evidence: "Consultant involvement begins" and "consultant tensions emerge" are credible but not specific.

Impact: Fine now; vulnerable later.

Action required: Governance Package should define each consultant's reason for involvement and evolving position.

### PLAUSIBLE

Finding: Discharge tension could become too obvious or too vague depending on later files.

Evidence: The current story says medically improved but operationally dangerous. That is the right target, but the later file plan must keep the decision balanced.

Impact: If the patient is obviously unsafe, there is no judgment test. If safety evidence is too thin, the discharge concern feels unsupported.

Action required: Later files should create a realistic gray zone: improved objective markers, persistent functional concerns, and plausible discharge pathways with risk.

### DISPUTED

Finding: No contradiction with the approved Brainstorm was identified.

Evidence: Patient identity, world type, 6-day hospitalization, HD6 close, mixed physiology, sepsis as contributor, steroid uncertainty, functional/disposition failure target, and major frictions/traps all match the approved foundation.

Impact: No redesign required.

Action required: None.

## 6. Failure Analysis

### What could collapse later?

- The case could collapse into "missed adrenal insufficiency" if steroid physiology is over-weighted.
- The case could collapse into "sepsis explains everything" if later documents do not keep persistent functional, medication, and steroid-timeline concerns visible.
- The discharge decision could become trivial if the patient is either obviously unsafe or obviously ready.
- Consultant friction could feel artificial if each specialty is reduced to a one-note position.
- The HF-AKI medication trap could become either too easy or unsafe if restart/hold reasoning is not tied to BP, creatinine trend, volume status, and symptom trajectory.
- Traceability could fail if key facts appear in expected outputs without file substrate.

### What feels underdeveloped?

- Exact consultant triggers and timestamps.
- Exact source-of-truth hierarchy.
- Exact calendar skeleton and milestones.
- How steroid inconsistency is discovered without making the answer too easy.
- How family concern is documented and weighted against objective improvement.
- How PT/OT/nursing concerns are buried but still findable.

### What would a hostile reviewer challenge?

- Whether HD4 is too convenient as the point when tensions and steroid inconsistency appear together.
- Whether the case truly meets complexity targets once translated into final World Spec.
- Whether "operationally dangerous" is supported by documents rather than asserted.
- Whether all final tasks are independent and anchored after the world close.
- Whether the World Spec includes a source-of-truth hierarchy and Decision Friction Table.

### What would a physician reviewer challenge?

- Whether steroid management is appropriately cautious without implying adrenal insufficiency is the answer.
- Whether HF guideline-directed therapy decisions are realistic in the context of AKI/hypotension.
- Whether the family concern is clinically meaningful rather than a generic discharge obstacle.
- Whether the near-fall remains multi-factorial and not retroactively assigned to one favored cause.

## Required Carry-Forward Watch Items

These are not skeleton blockers:

1. Convert HD1-HD6 into exact calendar dates and milestone rows.
2. Define synthetic MRN, DOB/age consistency, allergies, code status, height, weight, and BMI.
3. Create a source-of-truth hierarchy before any file plan.
4. Define consultant triggers, timestamps, and recommendation evolution.
5. Preserve balanced discharge ambiguity.
6. Expand World Spec complexity visibly to 12-15 comorbidities and 18-22 medications.
7. Consolidate task architecture into 3-5 distinct catalog workflows.
8. Plan administrative deliverable decision without changing approved Brainstorm concepts prematurely.
9. Build traceability from every future expected-output fact to file substrate.

## Overall Recommendation

GO.

Clinical Story Skeleton v1 is coherent, clinically realistic, aligned with the approved Brainstorm, and suitable to lock as the foundation for the next packages.

Proceed next to Pass 3 - Identity Package, then Pass 4 - Governance Package. Do not draft the World Spec, create a final file inventory, create task prompts, write golden responses, or write grader guidance.
